Histologic, electron microscopic, and immunohistochemical studies were made to analyze the structural features and the cellular composition of the pulmonary lesions produced in rats by the administration of interleukin-2 (IL-2). This agent induced pulmonary edema; thickening of alveolar septa; damage to endothelial cells in capillaries and venules, marked interstitial infiltration by cytotoxic T lymphocytes, lymphokine-activated killer (LAK) cells, macrophages, and dendritic cells (as demonstrated by cell counting in preparations stained immunohistochemically with peroxidase- and fluorochrome-labeled antibodies); and injury to bronchiolar and alveolar epithelial cells. Granular and agranular lymphocytes often were closely apposed to endothelial cells in capillaries and venules. Contacts between lymphocytes and type II alveolar epithelial cells also were observed. Damaged type II alveolar epithelial cells showed nuclear and cytoplasmic features that are considered indicative of apoptosis (confirmed by nick end labeling). Phagocytosis of apoptotic bodies by macrophages was occasionally found. These results support the concept that IL-2 induces cytotoxic vascular and parenchymal cell damage that is mediated by LAK cells and cytotoxic T lymphocytes, which make contacts with endothelial cells and type II alveolar epithelial cells. This damage appears to be exacerbated by the secondary release of a variety of vasoactive agents and inflammatory mediators.
Anderson TD, Hayes TJ, Gately MK, Bontempo JM, Stem LL, and Truitt GA (1988). Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes: Separation of efficacy and toxicity by selective lymphocyte subset depletion. Lab. Invest. 59: 598-612.
2.
Aronson FR, Libby P., Brandon EP, Janicka MW, and Mier JW (1988). IL-2 rapidly induces natural killer cell adhesion to human endothelial cells: A potential mechanism for endothelial injury. J. Immunol. 141: 158-163.
3.
Bowers WE and Goodell EM (1989). Dendritic cell ontogeny. Res. Immunol. 140: 880-883.
4.
Brideau RJ, Carter PB, McMaster WR, Mason DW, and Williams AF (1980). Two subsets of rat T-lymphocytes defined with monoclonal antibodies. Eur. J. Immunol. 10: 609-615.
5.
Cohen PJ, Lotze MT, Roberts JR, Rosenberg SA, and Jaffe ES (1987). The immunopathology of sequential tumor biopsies in patients treated with interleukin-2 : Correlation of response with T-cell infiltration and HLA-DR expression. Am. J. Pathol. 129: 208-216.
6.
Conant EF, Fox KR, and Miller WT (1989). Pulmonary edema as a complication of interleukin-2 therapy. Am. J. Roentgenol. 152: 749-752.
7.
Corcoran GB, Fix L., Jones DP, Moslen MT, Nicotera P., Oberhammer FA, and Buttyan R. (1994). Apoptosis : Molecular control point in toxicity . Toxicol. Appl. Pharmacol. 128: 169-181.
8.
Cotran RS, Pober JS, Gimbrone MA Jr, Springer TA, Wiebke EA, Gaspari AA, Rosenberg SA, and Lotze MT (1988). Endothelial activation during interleukin-2 immunotherapy: A possible mechanism for the vascular leak syndrome. J. Immunol . 140: 1883-1888.
9.
Damle NK, Doyle LV, Bender JA, and Bradley EC (1987). Interleukin-2 activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis . J. Immunol. 138: 1779-1785.
10.
Dijkstra CD , Dopp EA, Joling P., and Kraal G. (1985). The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology54: 589-599.
11.
Duke SS, King LS, Jones MR, Newman JH, Brigham KL, and Forbes JT (1989). Human recombinant interleukin 2-activated sheep lymphocytes lyse sheep pulmonary microvascular endothelial cells. Cell Immunol. 122: 188-199.
12.
Edidin M. (1986). Major histocompatibility complex haplotypes and the cell physiology of peptide hormones. Hum. Immunol. 15: 357-365.
13.
Edwards MJ, Miller FN, Sims DE, Abney DL, Schuschke DA, and Corey TS (1992). Interleukin-2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Cancer Res. 52: 3425-3431.
14.
Elliott BE, Carlow DA, Rodricks AM, and Wade A. (1989). Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer Res. 53: 181-245.
15.
Fujita S., Puri RK, Yu ZX, Travis WD, and Ferrans VJ (1991). An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2. Cancer68: 2169-2174.
16.
Fukumoto T. , McMaster RW, and Williams AF (1982). Mouse monoclonal antibodies against rat major histocompatibility antigens: Two la antigens and expression of Ia and class I antigens in rat thymus. Eur . J. Immunol . 12: 237-243.
17.
Gong JL , McCarthy KM, Telford J., Tamatani T., Miyasaka M., and Schneeberger EE (1992). Intraepithelial airway dendritic cells: A distinct subset of pulmonary dendritic cells obtained by microdissection. J. Exp. Med. 175: 797-807.
18.
Heslop HE , Gottlieb DJ, Bianchi AC, Meager A., Prentice HG, Mehta AB, Hoffbrand AV, and Brenner MK (1989). In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation . Blood74: 1374-1380.
19.
Holt PG, Oliver J., McMenamin C., and Schon-Hegrad MA (1992). Studies on the surface phenotype and functions of dendritic cells in parenchymal lung tissue of the rat. Immunology75: 582-587.
20.
Inaba K., Yong JW, and Steinman RM (1987). Direct activation of CD8+ cytotoxic T-lymphocytes by dendritic cells. J. Exp. Med. 166: 182-194.
21.
Kasai M., Iwamori M., Nagai Y., Okumura K., and Tada T. (1980). A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10: 175-180.
22.
Kawanami O. , Ferrans VJ, and Crystal RG (1982). Structure of alveolar epithelial cells in patients with fibrotic lung disorders . Lab. Invest. 46: 39-53.
23.
Klausner JM , Paterson IS, Goldman G., Kobzik L., Lelcuk S., Skornick Y., Eberlein T., Valeri CR, Shepro D., and Hechtman HB (1991). Interleukin-2-induced lung injury is mediated by oxygen free radicals . Surgery109: 169-175.
24.
Kradin RL, McCarthy KM, Xia W., Lazarus D., and Schneeberger EE (1991). Accessory cells of lung. Interferon-gamma increases Ia+ dendritic cells in the lung without augmenting their accessory activities . Am. J. Respir. Cell Mol. Biol. 4: 210-218.
25.
Kragel AH, Travis WD, Feinberg L., Pittaluga S., Striker LM, Roberts WC, Lotze MT, Yang JJ, and Rosenberg SA (1990). Pathologic findings associated with interleukin-2-based immunotherapy for cancer: A postmortem study of 19 patients. Hum. Pathol. 21: 493-502.
26.
Lissoni P., Barni S., Cattaneo G., Archili C., Crispino S., Tancini G., D'angelo L., Magni S., and Florelli G. (1990). Activation of the complement system during immunotherapy of cancer with interleukin-2: A possible explanation of the capillary leak syndrome. Int. J. Biol. Markers5: 195-197.
27.
McMaster WR and Williams AF (1979). Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur. J. Immunol. 9: 426-433.
28.
Mier JW, Vachino G., van der Meer JW, Numerof RP, Adams S., Cannon JG, Bernheim HA, Atkins MB, Parkinson DR, and Dinarello CA (1988). Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J. Clin. Immunol. 8: 426-436.
29.
Numerof RP, Aronson FR, and Mier JM (1988). IL-2 stimulates the production of IL-1α and IL-1β by human peripheral blood mononuclear cells. J. Immunol. 141: 4250-4257.
30.
Parham P.Barnstable CJ, and Bodmer WF (1979). Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B.C antigens. J. Immunol. 123: 342-349.
31.
Polunovsky, VA, Chen B., Henke C., Snover D., Wendt C., Ingbar DH, and Bitterman PB (1993). Role of mesenchymal cell death in lung remodeling after injury. J. Clin. Invest. 92: 388-397.
32.
Puri, RK, Travis WD, and Rosenberg SA (1990). In vivo administration of interferon α and interleukin 2 induces proliferation of lymphoid cells in the organs of mice . Cancer Res. 50: 5543-5550.
33.
Queluz TT, Brunda M., Vladutiu AO, Brentjens JR, and Andres G. (1991). Morphological basis of pulmonary edema in mice with cytokine-induced vascular leak syndrome. Exp. Lung Res . 17: 1095-1108.
34.
Rabinovici R., Sofronski MD, Renz JF, Hillegas LM, Esser KM, Vernick J., and Feuerstein G. (1992). Platelet activating factor mediates interleukin-2-induced lung injury in the rat. J. Clin. Invest. 89: 1669-1673.
35.
Rochester CL , Goodel EM, Stoltenborg JK, and Bowers WE (1988). Dendritic cells from rat lung are potent accessory cells. Am. Rev. Respir. Dis . 138: 121-128.
36.
Saxon RR, Klein JS, Bar MH, Blanc P., Gamsu G., Webb WR, and Aronson FR (1991). Pathogenesis of pulmonary edema during interleukin-2 therapy: Correlation of chest radiographic and clinical findings in 54 patients . Am. J. Roentgenol. 156: 281-285.
37.
Stephens KE , Ishizaka A., Larrick JW, and Raffin TA (1988). Tumor necrosis factor causes increased pulmonary permeability and edema: Comparison to septic acute lung injury. Am. Rev. Respir. Dis. 137: 1364-1370.
38.
Strieter RM , Remick DG, Lynch JP, Spengler RN, and Kunkel SL (1989). Interleukin-2 induced tumor necrosis factor-alpha (TNF-α) gene expression in human alveolar macrophages and blood monocytes . Am. Rev. Respir. Dis. 139: 335-342.
39.
Trinchieri G. (1992). Natural killer (NK) cells . In: Encyclopedia of Immunology, IM Roitt and PJ Delves (eds). Academic Press, New York, pp. 1136-1138.
40.
van Haelst Pisani C., Kovach JS, Kita H., Leiferman KM, Gleich GJ, Silver JE, Dennin R., and Abrams J. (1991). Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood78: 1538-1544.
41.
Welbourn R. , Goldman G., Kobzik L., Valeri CR, Shepro D., and Hechtman HB (1990). Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2. Ann. Surg. 212: 728-733.
42.
Wendt CHPolunovsky VAPeterson MSBitterman PB, and Ingbar DH (1994). Alveolar epithelial cells regulate the induction of endothelial cell apoptosis. Am. J. Phvsiol. 267: C893-C900.
43.
White RA, Mason DW, Williams AFGalfre G. and Milstein C. (1978). T-lymphocyte heterogeneity in the rat: Separation of functional subpopulations using a monoclonal antibody. J. Exp. Med. 148: 664-673.
44.
Yamamoto A. , Wenthold RJ Jr, Zhang J., Herman EH, and Ferrans VJ (1995). Immunofluorescence techniques for the identification of immune effector cells in rat heart: Applications to the study of the myocarditis induced by interleukin-2 . J. Mol. Cell. Car-diol. 27: 307-319.
45.
Yi ES and Ulich TR (1992). Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules . Am. J. Pathol. 140: 659-663.
46.
Zhang J., Yu ZX, Fujita S., Yamaguchi ML, and Ferrans VJ (1993). Interstitial dendritic cells of the heart: Quantitative and ultrastructural changes in experimental myocardial infarction. Circulation87: 909-920.
47.
Zhang J., Yu ZX, Hilbert SL, Yamaguchi ML, Chadwick DP, Herman EH, and Ferrans VJ (1993). Cardiotoxicity of human recombinant interleukin-2 in rats: A morphological study. Circulation87: 1340-1353.
